Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa J Anderson

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|October 20, 2004
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonanceLisa J Anderson, Mark A Westwood, Sally Holden, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 24, 2007
Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial ironMark A Westwood, Lisa J Anderson, Alicia M Maceira, et al.
Journal of Cardiac Failure|April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial FindingsHitesh C Patel, Carl Hayward, Jason N Dungu, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Circulation. Heart Failure|September 14, 2016
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac AmyloidosisJason N Dungu, Sofia A Papadopoulou, Katharine Wykes, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 31, 2007
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathyMark A Westwood, Farrukh Shah, Lisa J Anderson, et al.
Cardiology and Therapy|May 27, 2026
Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe StudyKevin M Alexander, Shun Kohsaka, Steen Hvitfeldt Poulsen, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
JACC. Cardiovascular Imaging|January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosisJason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
American Heart Journal|July 17, 2012
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patientsJason Dungu, Prayman T Sattianayagam, Carol J Whelan, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|October 20, 2004
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonanceLisa J Anderson, Mark A Westwood, Sally Holden, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 24, 2007
Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial ironMark A Westwood, Lisa J Anderson, Alicia M Maceira, et al.
Journal of Cardiac Failure|April 25, 2017
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial FindingsHitesh C Patel, Carl Hayward, Jason N Dungu, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Circulation. Heart Failure|September 14, 2016
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac AmyloidosisJason N Dungu, Sofia A Papadopoulou, Katharine Wykes, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 31, 2007
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathyMark A Westwood, Farrukh Shah, Lisa J Anderson, et al.
Cardiology and Therapy|May 27, 2026
Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe StudyKevin M Alexander, Shun Kohsaka, Steen Hvitfeldt Poulsen, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
JACC. Cardiovascular Imaging|January 14, 2014
CMR-based differentiation of AL and ATTR cardiac amyloidosisJason N Dungu, Oswaldo Valencia, Jennifer H Pinney, et al.
American Heart Journal|July 17, 2012
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patientsJason Dungu, Prayman T Sattianayagam, Carol J Whelan, et al.
Pageof 4